148 related articles for article (PubMed ID: 3549249)
1. Cyclosporine nephrotoxicity can be minimized by careful monitoring of whole blood trough levels.
Uchida K; Nakanisi N; Yamada N; Tominaga Y; Orihara A; Kondo T; Morimoto T; Morozumi K; Kano T; Takagi H
Dev Toxicol Environ Sci; 1986; 14():163-6. PubMed ID: 3549249
[No Abstract] [Full Text] [Related]
2. Cyclosporine blood level monitoring: the early posttransplant period.
Ferguson RM; Canafax DM; Sawchuck RT; Simmons RL
Transplant Proc; 1986 Apr; 18(2 Suppl 1):113-22. PubMed ID: 3515676
[No Abstract] [Full Text] [Related]
3. Minimal low dosage of cyclosporine therapy in renal transplantation by careful monitoring of high-performance liquid chromatography whole blood trough levels.
Uchida K; Yamada N; Orihara A; Tominaga Y; Tanaka Y; Hayashi S; Kondo T; Morozumi K; Satake M; Taira N
Transplant Proc; 1988 Apr; 20(2 Suppl 2):394-401. PubMed ID: 3284083
[No Abstract] [Full Text] [Related]
4. Correlation between whole blood and plasma cyclosporine blood levels.
Uchida K; Orihara A; Tominaga Y; Yamada N; Nakanishi N; Kawai M; Kondo T; Akaza T; Morozumi K; Morimoto T
Transplant Proc; 1987 Feb; 19(1 Pt 2):1764-8. PubMed ID: 3547881
[No Abstract] [Full Text] [Related]
5. Monitoring of cyclosporine blood levels with polyclonal and monoclonal assays during episodes of renal graft dysfunction.
Martinez L; Foradori A; Vaccarezza A; Martinez P; Rodriguez L
Transplant Proc; 1989 Feb; 21(1 Pt 2):1490-1. PubMed ID: 2652479
[No Abstract] [Full Text] [Related]
6. Usefulness of cyclosporine levels one to six months posttransplant.
Steinmuller DR
Transplant Proc; 1986 Apr; 18(2 Suppl 1):158-67. PubMed ID: 3515684
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection.
Veremis SA; Maddux MS; Tang IY; Millner SN; Prasad R; Pollak R; Mozes MF
Transplant Proc; 1989 Feb; 21(1 Pt 2):1476-7. PubMed ID: 2652473
[No Abstract] [Full Text] [Related]
8. Cyclosporine monitoring with polyclonal and specific monoclonal antibodies during episodes of renal allograft dysfunction.
Holt DW; Marsden JT; Johnston A; Taube DH
Transplant Proc; 1989 Feb; 21(1 Pt 2):1482-4. PubMed ID: 2652475
[No Abstract] [Full Text] [Related]
9. The value of serial serum trough cyclosporine levels in human renal transplantation.
Kahan BD; Wideman CA; Reid M; Gibbons S; Jarowenko M; Flechner S; Van Buren CT
Transplant Proc; 1984 Oct; 16(5):1195-9. PubMed ID: 6385376
[No Abstract] [Full Text] [Related]
10. Rejection and nephrotoxicity. Diagnostic problems with cyclosporine in renal transplantation.
Pichlmayr R; Wonigeit K; Ringe B; Block T; Raab R; Heigel B; Neuhaus P
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():947-60. PubMed ID: 3887390
[No Abstract] [Full Text] [Related]
11. Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period?
Mahalati K; Lawen J; Kiberd B; Belitsky P
J Urol; 2000 Jan; 163(1):37-41. PubMed ID: 10604309
[TBL] [Abstract][Full Text] [Related]
12. [Clinical renal transplantation: exfoliative urinary cytology in the evaluation of nephrotoxicity induced by cyclosporin therapy].
Stella F; Alfani D; Renna Molajoni E; Rossi M; Rossi Lemeni A; Stella C; Di Tondo U; Troccoli R; Cortesini R
Quad Sclavo Diagn; 1984 Sep; 20(3):295-303. PubMed ID: 6397762
[TBL] [Abstract][Full Text] [Related]
13. Is cyclosporine's nephrotoxicity related to its immunosuppressive effectiveness?
Hakim M; White DJ; Cory-Pearce R; English TA; Wallwork J
J Heart Transplant; 1985 Feb; 4(2):217-9. PubMed ID: 3916489
[TBL] [Abstract][Full Text] [Related]
14. Plasma thrombomodulin levels as an indicator of vascular injury caused by cyclosporine nephrotoxicity.
Yoshida M; Kozaki M; Ioya N; Kaji N; Tamaki T; Hiraishi S; Ishii H; Kazama M; Fukutomi K; Nagasawa T
Transplantation; 1990 Dec; 50(6):1066-9. PubMed ID: 2175057
[No Abstract] [Full Text] [Related]
15. Morphologic diagnosis of cyclosporine nephrotoxicity.
Mihatsch MJ; Thiel G; Ryffel B
Semin Diagn Pathol; 1988 Feb; 5(1):104-21. PubMed ID: 3281200
[No Abstract] [Full Text] [Related]
16. Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection, or good renal function: comparative high-performance liquid chromatography and monoclonal radioimmunoassay studies.
Rosano TG; Pell MA; Freed BM; Dybas MT; Lempert N
Transplant Proc; 1988 Apr; 20(2 Suppl 2):330-8. PubMed ID: 3284076
[No Abstract] [Full Text] [Related]
17. Cyclosporine in the first month posttransplant.
Rolles K; Calne RY
Transplant Proc; 1986 Apr; 18(2 Suppl 1):55-8. PubMed ID: 3515695
[No Abstract] [Full Text] [Related]
18. A comparison of the clinical, histopathologic, cytologic, and biochemical features of renal transplant rejection, cyclosporine A nephrotoxicity, and stable renal function.
Taube D; Neild G; Hobby P; Holt D; Welsh K; Cameron JS
Transplant Proc; 1985 Aug; 17(4 Suppl 1):179-84. PubMed ID: 3895658
[No Abstract] [Full Text] [Related]
19. Differentiation of acute rejection from acute cyclosporine nephrotoxicity in renal transplants peripheral T cell subset counts.
Shen SY; Weir MR; Revie DR; Dagher FJ; Bentley FR; Chretien PB
Transplant Proc; 1987 Feb; 19(1 Pt 2):1776-9. PubMed ID: 2950634
[No Abstract] [Full Text] [Related]
20. The area under the concentration-time curve versus trough and peak blood level monitoring in renal transplant recipients on cyclosporine.
Halim MA; Nampoory MR; Johny KV; Donia F; Hamid MH; Said T; Nair MP; Mansour M; Al-Muzairai I; Samhan M; Al-Mousawi M
Transplant Proc; 2005 Sep; 37(7):3019-21. PubMed ID: 16213291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
